Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (8627)	6/5/2003 4:24:27 PM
From: nigel bates	Respond to of 52153

Nothing wrong with that. It is the other part of the hill that is difficult to manage. Having perfected my 'rabbit in the headlights' technique on the way down, it's gratifying to find that it's serving me pretty well on the way back up...

To: Icebrg who wrote (8627)	6/5/2003 5:17:50 PM
From: Biomaven	Read Replies (3) \| Respond to of 52153

I am not sure I agree to the idea of selling just because the portfolio has done well. There speaks a man that must not have fully participated in the biotech bubble and bust. <g> Nobody rings a bell at the top. The biotech bubble initially burst when the famous "gene patenting" Clinton/Blair announcement was misreported. We on SI "knew" that the news didn't warrant the sharp correction that ensued. Days like today are few and far between. As I said during the bubble, the profits from a day like this can buy a lot of valium. Clearly there is some froth in the air - not quite sure how much froth makes a full-fledged bubble, though. <g> Peter